Progress of platelet-rich plasma in diabetic foot disease therapy

doi:10.3877/cma.j.issn.1673-9450.2018.02.014

Abstract

Abstract:

Diabetic foot are chronic refractory wounds that pose a major health burden to society. Numerous advanced treatment options for the management of diabetic foot have been explored, including bioengineered skin substitutes, hyperbaric oxygen therapy and negative pressure dressings. However, the effective therapies are still lacking. Platelet-rich plasma (PRP) is rich in platelet, white blood cells, growth factors and other components. It has the characteristics of promoting wound repair, reducing wound pain, sealing and protecting wounds and inhibiting local bacterial growth that has a definite effect in the application of diabetic foot therapy. With the gradual maturity of the therapy of PRP, the use of PRP will be the most promising treatment for diabetic foot.

Key words: Platelet-rich plasma, Diabetic foot, Chronic wounds

Jingru Wang, Ronghua Yang, Xiaodong Chen. Progress of platelet-rich plasma in diabetic foot disease therapy[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2018, 13(02): 139-141.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhssyxfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1673-9450.2018.02.014

https://zhssyxfzz.cma-cmc.com.cn/EN/Y2018/V13/I02/139

References 32

[1]	Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes and cost of foot ulcers in patients with diabetes[J]. Diabetes Care, 1999, 22(3):382-387.
[2]	Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes[J]. JAMA, 2005, 293(2):217-228.
[3]	Blume PA, Walters J, Payne W, et al. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial[J]. Diabetes Care, 2008, 31(4):631-636.
[4]	Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers[J]. Arch Surg, 2002, 137(7):822-827.
[5]	Wunderlich RP, Peters EJ, Lavery LA. Systemic hyperbaric oxygen therapy: lower-extremity wound healing and the diabetic foot[J]. Diabetes Care, 2000, 23(10):1551-1555.
[6]	Carter MJ, Fylling CP, Parnell LK. Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis[J]. Eplasty, 2011, 11:e38.
[7]	Piccin A, Di Pierro AM, Canzian L, et al. Platelet gel: a new therapeutic tool with great potential[J]. Blood Transfus, 2017, 15(4):333-340.
[8]	Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing[J]. Wound Repair Regen, 2008, 16(5):585-601.
[9]	Hunt TK, Hopf H, Hussain Z. Physiology of wound healing[J]. Adv Skin Wound Care, 2000, 13(2 Suppl):6-11.;
[10]	吴护群，陈戈，卢汶. 糖尿病足的基础知识教育及防治[J]. 实用心脑肺血管病杂志，2010, 18(5):572-573.
[11]	张喜英，王涤非. 2型糖尿病患者糖尿病足危险因素研究[J]. 中国全科医学，2011, 14(5):1629-1634.
[12]	关小宏，杨彩哲，吴白石. 糖尿病足感染的特点与治疗[J]. 中华医院感染学杂志，2012, 22(19):4237-4239.
[13]	严龙宗，陈斌. 慢性创面愈合的细胞治疗[J]. 中国组织工程研究，2013, 17(46):8096-8101.
[14]	Ahmed M, Reffat SA, Hassan A, et al. Platelet-Rich Plasma for the Treatment of Clean Diabetic Foot Ulcers[J]. Ann Vasc Surg, 2017, 38:206-211.
[15]	Suthar M, Gupta S, Bukhari S, et al. Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series[J]. J Biomed Sci, 2017, 24(1):16.
[16]	Driver VR, Hanft J, Fylling CP, et al. A prospective, randomized, controlled trial of autologou platelet-rich plasma gel for the treatment of diabetic foot ulcers[J]. Ostomy Wound Manage, 2006, 52(6):68-70, 72, 74 passim.
[17]	Martinez-Zapata MJ, Martì-Carvajal AJ, Solà L, et al. Autologous platelet-rich plasma for treating chronic wounds[J]. Cochrane Database Syst Rev, 2016, 25(5):CD006899.
[18]	Winter GD. Formantion of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig[J]. Nature, 1962, 193(13):293-294.
[19]	肖黎，吴石白，关小宏. 敷料在糖尿病足治疗中的应用现状及展望[J]. 医学综述，2014, 20(10):3762-3765.
[20]	Sommeling CE, Heyneman A, Hoeksema H, et.al. The use of platelet-rich plasma in plastic surgery: a systematic review[J]. J Plast Reconstr Aesthet Surg, 2013, 66(3):301-311.
[21]	Marx RE. Platelet-Rich Plasma (PRP): What Is PRP and What Is Not PRP？[J]. Implant Dent, 2001, 10(4):225-228.
[22]	Ching YH, Sutton TL, Pierpont YN, et al. The use of growth factors and other humoral agents to accelerate and enhance burn wound healing[J]. Eplasty, 2011, 11:e41.
[23]	何利平，王椿，陈大伟，等. APG治疗糖尿病难治性皮肤溃疡对创面肉芽组织中MMP-1, MMP-9及TIMP-1水平的影响[J]. 四川大学学报(医学版), 2012, 43(5):757-761.
[24]	Crowe MJ, Doetschman T, Greenhalgh DG. Delayed Wound healing in immunodeficient TGF-β1 knockout mice[J]. J Invest Dermatol, 2000, 115(1):3-11.
[25]	Davis VL, Abukabda AB, Radio NM, et al. Platelet-rich preparations to improve healing. Part II: platelet activation and enrichment, leukocyte inclusion, and other selection criteria[J]. J Oral Implantol, 2014, 40(4):511-521.
[26]	李明，章军辉，李淑敏，等. 应用自体富血小板血浆治疗慢性难愈性创面的实验研究[J/CD]. 中华关节外科杂志(电子版), 2016, 10(6):624-629.
[27]	Yeaman MR. The role of platelets in antimicrobial host defense[J]. Clin Infect Dis, 1997, 25(5):951-968; quiz 969-970.
[28]	王涛，曹萌，李拉克，等. 糖尿病足感染多药耐药菌的分布及耐药性与危险因素分析[J]. 中华医院感染学杂志，2015, 25(2):327-329.
[29]	杨阎峙，刘衡川，刘关键，等. 健康志愿者自体富血小板凝胶体外抑菌作用[J]. 中国修复重建外科杂志，2010, 24(5):571-576.
[30]	Bielecki M, Gazdzik TS, Arendt J, et al. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study[J]. J Bone Joint Surg Br, 2007, 89(3):417-420.
[31]	李立，柴益民. 富血小板血浆促糖尿病创面愈合机制的初步研究[J]. 上海医学，2017, 40(3):169-172.
[32]	Bendinelli P, Matteucci E, Dogliotti G, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF[J]. J Cell Physiol, 2010, 225(3):757-766.

Please choose a citation manager

Content to export